Mar 14 |
Autolus Therapeutics plc 2023 Q4 - Results - Earnings Call Presentation
|
Mar 14 |
Autolus Therapeutics GAAP EPS of -$1.20 misses by $0.10, revenue of $1.69M misses by $0.01M
|
Mar 14 |
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
|
Mar 14 |
Earnings Scheduled For March 14, 2024
|
Mar 13 |
Autolus Therapeutics FY 2023 Earnings Preview
|
Mar 12 |
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
|
Mar 11 |
Autolus Therapeutics announces publication in Blood Cancer Journal
|
Feb 29 |
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
|
Feb 23 |
BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time
|
Feb 22 |
Autolus Therapeutics announces publication in Nature Communications
|